Probiotics join the fight against superbugs in the gut
NCT ID NCT07707869
First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This study tests whether adding a probiotic supplement to standard antibiotics can better clear carbapenem-resistant bacteria from the gut. Participants are adults who carry these resistant germs but are not currently sick from them. The goal is to see if the probiotic helps eliminate the bacteria more safely and effectively than antibiotics alone.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a probiotic preparation taken by mouth alongside standard antibiotics
- What this could lead to
- If successful, this could offer a safer way to clear drug-resistant bacteria from the gut, reducing infection risk.
- What could go wrong
- This is a very small, early-stage study with only 20 participants, so results may not apply broadly. Probiotics may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARRIER STATE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Laboratory, 2nd Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310009, China
-
Clinical Laboratory, 2nd Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Superbug sleuths decode the DNA of drug-resistant e. coli to stop its spread
- Could a simple hand soak reveal cystic fibrosis risk?
- Could a common antibiotic spare Last-Resort drugs for ICU lung infections?
- Poop pills vs. superbugs: can a fecal transplant beat resistant gut bacteria?
- Hidden heat risk: one copy of CF gene may raise danger
- CF gene carriers may face hidden organ risks